FDA Drug recall D-0130-2019
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701
- FDA Drug
- Class II
- terminated
- Published 2018-10-31
On 2018-10-31 the FDA classified a Class II recall of Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701 by Rxq Compounding, citing subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0130-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-09-25 |
| Published | 2018-10-31 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Rxq Compounding |
| Distribution | US |
Product
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450
Reason
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Identifiers
| code_info | Lot# 04042018:58, Exp 10/17/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0130-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.